Cancer Focus
Venture capitalActively deployingHouston · Pre-Seed–Series A · 3 people tracked
Also known as BIG VENTURES MANAGEMENT COMPANY, LLC
Investment thesis
Cancer Focus Fund invests in oncology assets, targeting emerging cancer treatments such as immunotherapies, CAR-T and cell therapies, precision medicine, and radiotherapeutics. It sources promising oncology assets globally and relies on a Scientific Advisory Committee of MD Anderson experts to identify candidates ready for human clinical trials. Combining venture capital experience with MD Anderson's clinical and research expertise, the fund selects a small number of drugs worthy of investment, aiming to deliver both returns to investors and breakthroughs to cancer patients.
Source: firm website, verified Aug 11, 2026.
Team · 3 people
from the firm's websiteWhat they invest in
from 1 of 1 portfolio companiesAgTech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathAgTechSarasota, US
Christopher G. Cogan(Member and Director of the Manager)Kay D. Carter(Senior Vice President and Chief Financial Officer of Issuer)Ariane M. Dart(Director of the Manager)Robert G. Bartner(Director of the Manager)Ross P. Barrett(Member and Director of the Manager)
Board seatRoss P. Barrett· per SEC Form D · $7M raise · filed Feb 2016
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Cancer Focus invest at?
- Cancer Focus invests at the Pre-Seed, Seed, Series A stages.
- What sectors does Cancer Focus focus on?
- Cancer Focus focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Cancer Focus located?
- Cancer Focus is headquartered in Houston, US.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital's portfolio page showcasing companies across health, climate, and deeptech sectors.


